Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001628280-26-003146

Chief Research Officer sold 10,200 shares at $4.03 ($41,106)

  • Chief Research Officer acquired 29,166 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SMITH J. JEFFERSON Chief Research Officer 2026-01-20 Option exercise 10b5-1 +2,500 93,718 D
SMITH J. JEFFERSON Chief Research Officer 2026-01-20 Option exercise 10b5-1 +10,447 104,165 D
SMITH J. JEFFERSON Chief Research Officer 2026-01-21 Option exercise 10b5-1 +16,219 120,384 D
SMITH J. JEFFERSON Chief Research Officer 2026-01-21 Sale 10b5-1 −10,200 $4.03 $41,106 110,184 D
Derivatives
SMITH J. JEFFERSON Chief Research Officer 2026-01-20 Option exercise · Restricted Stock Units 10b5-1 −2,500 0 D
SMITH J. JEFFERSON Chief Research Officer 2026-01-20 Option exercise · Restricted Stock Units 10b5-1 −10,447 10,447 D
SMITH J. JEFFERSON Chief Research Officer 2026-01-20 Option exercise · Restricted Stock Units 10b5-1 −16,219 16,219 D
Open-market sales · 10,200 sh · avg $4.03 · $41,106
Loading xslF345X05/wk-form4_1769125699.xml…